Enoxaparin Sodium
NDC Package 0955-1003-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Enoxaparin Sodium is enoxaparin is used to prevent and treat harmful blood clots. Marketed by Sanofi-aventis U.s. Llc, this product is identified by NDC 0955-1003 and is authorized under FDA application NDA020164.

Identification & Billing

NDC Package Code
0955-1003-10
Package Description
10 CELLO PACK in 1 CARTON / 1 SYRINGE in 1 CELLO PACK (0955-1003-01) / .3 mL in 1 SYRINGE
Product Code
0955-1003
11-Digit Billing Format
00955100310
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
  • RxCUI: 854228 - enoxaparin sodium 30 MG in 0.3 ML Prefilled Syringe
  • RxCUI: 854228 - 0.3 ML enoxaparin sodium 100 MG/ML Prefilled Syringe
  • RxCUI: 854228 - 0.3 ML ENX sodium 100 MG/ML Prefilled Syringe
  • RxCUI: 854228 - enoxaparin sodium 30 MG per 0.3 ML Prefilled Syringe
  • RxCUI: 854235 - enoxaparin sodium 40 MG in 0.4 ML Prefilled Syringe

Clinical Specifications

Proprietary Name
Enoxaparin Sodium
Dosage Form
-
Usage Information
Enoxaparin is used to prevent and treat harmful blood clots. This helps to reduce the risk of a stroke or heart attack. This medication helps keep your blood flowing smoothly by lowering the activity of clotting proteins in the blood. Enoxaparin is an anticoagulant, also known as a "blood thinner." It is a type of heparin. Conditions which increase your risk of developing blood clots include certain types of surgeries (such as knee/hip replacement, abdominal), long periods of being immobile, certain types of heart attack, and a specific type of chest pain called unstable angina. For some medical conditions, enoxaparin may be used in combination with other "blood thinners."

Regulatory & Marketing

Labeler Name
Sanofi-aventis U.s. Llc
FDA Application #
NDA020164
Marketing Category
NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
Start Marketing Date
10-03-2011
End Marketing Date
02-29-2024
Listing Expiration
02-29-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0955-1003-10 identifies a specific commercial package of 10 cello pack in 1 carton / 1 syringe in 1 cello pack (0955-1003-01) / .3 ml in 1 syringe of Enoxaparin Sodium, labeled by Sanofi-aventis U.s. Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sanofi-aventis U.s. Llc on October 03, 2011. The current certification is valid through February 29, 2024.

What are the primary indications for this medication?

Enoxaparin is used to prevent and treat harmful blood clots. This helps to reduce the risk of a stroke or heart attack. This medication helps keep your blood flowing smoothly by lowering the activity of clotting proteins in the blood. Enoxaparin is an anticoagulant, also known as a "blood thinner." It is a type of heparin. Conditions which increase your risk of developing blood clots include certain types of surgeries (such as knee/hip replacement, abdominal), long periods of being immobile, certain types of heart attack, and a specific type of chest pain called unstable angina. For some medical conditions, enoxaparin may be used in combination with other "blood thinners."

How is this Sanofi-aventis U.s. Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00955100310. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0955-1003-10
11-Digit CMS (5-4-2)
00955-1003-10

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.